SE461147B - Karbostyrilderivat och farmaceutisk komposition innehaallande dem - Google Patents

Karbostyrilderivat och farmaceutisk komposition innehaallande dem

Info

Publication number
SE461147B
SE461147B SE8102690A SE8102690A SE461147B SE 461147 B SE461147 B SE 461147B SE 8102690 A SE8102690 A SE 8102690A SE 8102690 A SE8102690 A SE 8102690A SE 461147 B SE461147 B SE 461147B
Authority
SE
Sweden
Prior art keywords
dihydrocarbostyril
group
propoxy
lower alkyl
crystals
Prior art date
Application number
SE8102690A
Other languages
English (en)
Swedish (sv)
Other versions
SE8102690L (sv
Inventor
T Nishi
T Tanaka
K Nakagawa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SE8102690L publication Critical patent/SE8102690L/xx
Publication of SE461147B publication Critical patent/SE461147B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
SE8102690A 1980-02-29 1981-04-29 Karbostyrilderivat och farmaceutisk komposition innehaallande dem SE461147B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2565880A JPS56122356A (en) 1980-02-29 1980-02-29 Carbostyril derivative

Publications (2)

Publication Number Publication Date
SE8102690L SE8102690L (sv) 1981-08-30
SE461147B true SE461147B (sv) 1990-01-15

Family

ID=12171902

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8102690A SE461147B (sv) 1980-02-29 1981-04-29 Karbostyrilderivat och farmaceutisk komposition innehaallande dem

Country Status (24)

Country Link
US (1) US4435404A (de)
JP (1) JPS56122356A (de)
KR (2) KR860002099B1 (de)
AT (1) AT381493B (de)
AU (1) AU532319B2 (de)
BE (1) BE883713A (de)
CA (1) CA1159068A (de)
CH (1) CH647765A5 (de)
DE (1) DE3049959T1 (de)
DK (1) DK151956C (de)
ES (1) ES492230A0 (de)
FI (1) FI76321C (de)
FR (1) FR2477149A1 (de)
GB (1) GB2070588B (de)
IT (1) IT1129812B (de)
MX (1) MX6752E (de)
NL (1) NL185146C (de)
NO (1) NO160512C (de)
PH (1) PH18532A (de)
PT (1) PT71359B (de)
SE (1) SE461147B (de)
SU (2) SU1169535A3 (de)
WO (1) WO1981002421A1 (de)
ZA (1) ZA803322B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578381A (en) * 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
DE3434271A1 (de) * 1984-09-19 1986-03-20 Beiersdorf Ag, 2000 Hamburg Substituierte 3,4-dihydro-chinolin-2(1h)-one verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
JP2753622B2 (ja) * 1988-05-02 1998-05-20 大塚製薬株式会社 カルボスチリル誘導体
US5227381A (en) * 1988-05-02 1993-07-13 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative
AU653060B2 (en) * 1991-08-23 1994-09-15 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative and platelet agglutination inhibitor
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−3,4−ジヒドロカルボスチリル誘導体
US7208497B2 (en) 2001-07-02 2007-04-24 Novo Nordisk A/S Substituted piperazines and diazepanes
WO2011021676A1 (ja) 2009-08-21 2011-02-24 大塚製薬株式会社 ベンゾ[b][1,4]ジアゼピン-2,4-ジオン化合物の製造方法
TWI481601B (zh) * 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1021522A (en) * 1963-05-10 1966-03-02 Ici Ltd 2-quinolone derivatives
DE1527937A1 (de) * 1966-12-10 1969-11-13 Blanc & Co Verfahren zur Herstellung eines sich konisch verjuengenden,einen nach aussen abgewinkelten flachen Rand aufweisenden Hohlteils sowie Einrichtung zur Durchfuehrung des Verfahrens
JPS48103590A (de) * 1972-04-13 1973-12-25
JPS5082218A (de) * 1973-11-10 1975-07-03
JPS5310988B2 (de) * 1974-04-25 1978-04-18
JPS5318030B2 (de) * 1974-05-20 1978-06-13
US4313947A (en) 1974-06-24 1982-02-02 Otsuka Pharmaceutical Co., Ltd. Platelet aggregation inhibiting 2-oxyindoles, their compositions and method of use
FI59246C (fi) * 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
JPS5273879A (en) * 1975-12-18 1977-06-21 Otsuka Pharmaceut Co Ltd Synthesis of ester derivatives
JPS545981A (en) * 1977-06-10 1979-01-17 Otsuka Pharmaceut Co Ltd Carbostyryl derivatives
IE46852B1 (en) * 1977-06-10 1983-10-05 Otsuka Pharma Co Ltd Novel carbostyril derivatives

Also Published As

Publication number Publication date
DE3049959T1 (de) 1982-07-29
FI76321B (fi) 1988-06-30
ES8105290A1 (es) 1981-05-16
GB2070588A (en) 1981-09-09
WO1981002421A1 (en) 1981-09-03
AU5985980A (en) 1981-09-11
NL185146C (nl) 1990-02-01
CH647765A5 (de) 1985-02-15
ES492230A0 (es) 1981-05-16
FI801843A (fi) 1981-08-30
DK250381A (da) 1981-09-03
MX6752E (es) 1986-06-25
AT381493B (de) 1986-10-27
PH18532A (en) 1985-08-09
SE8102690L (sv) 1981-08-30
PT71359B (en) 1981-10-21
DK151956B (da) 1988-01-18
US4435404A (en) 1984-03-06
KR830002713A (ko) 1983-05-30
BE883713A (fr) 1980-12-09
CA1159068A (en) 1983-12-20
SU1169535A3 (ru) 1985-07-23
NL8020199A (nl) 1981-12-01
FI76321C (fi) 1988-10-10
DE3049959C2 (de) 1993-07-08
FR2477149A1 (fr) 1981-09-04
GB2070588B (en) 1983-10-19
SU1395140A3 (ru) 1988-05-07
NO813477L (no) 1981-10-15
DK151956C (da) 1988-08-15
NO160512B (no) 1989-01-16
JPS6334845B2 (de) 1988-07-12
IT1129812B (it) 1986-06-11
KR860002099B1 (ko) 1986-11-25
PT71359A (en) 1980-07-01
IT8067888A0 (it) 1980-06-06
ZA803322B (en) 1982-01-27
KR860002100B1 (ko) 1986-11-25
AU532319B2 (en) 1983-09-22
ATA909480A (de) 1986-03-15
NL185146B (nl) 1989-09-01
FR2477149B1 (de) 1983-06-24
KR840004681A (ko) 1984-10-22
NO160512C (no) 1989-04-26
JPS56122356A (en) 1981-09-25

Similar Documents

Publication Publication Date Title
SE432252B (sv) Tetrazolyl-alkoxi-karbostyrilderivat
US4564619A (en) Carbostyril derivative
CA2031693A1 (en) Antiarrhytmic agents
Fujioka et al. Novel positive inotropic agents: synthesis and biological activities of 6-(3-amino-2-hydroxypropoxy)-2 (1H)-quinolinone derivatives
EP0385237A2 (de) 2-(1-Piperazinyl)-4-phenylcycloalkanpyridin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
EP1049700B9 (de) Chemokin rezeptor antagonisten und verwndung
SE461147B (sv) Karbostyrilderivat och farmaceutisk komposition innehaallande dem
JPS6320235B2 (de)
US5250547A (en) Benzopyran derivatives
US5760074A (en) Treatment
CA2093633A1 (en) Carbostyril derivative and platelets aggregation inhibitory agent
US4593035A (en) Carbostyril derivatives
EP0618206B1 (de) Pharmazeutische Verbindungen
FI95250B (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
CA1205807A (en) Carbostyril derivative
RU2083572C1 (ru) Производные дигидронафтопиранов или их соли, способ их получения и фармацевтическая композиция, подавляющая пролиферацию клеток
US5405848A (en) Substituted thiazolylaminotetrahydropyridopyrimidines derivatives useful as platelet aggregation inhibitors
US5656633A (en) Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent, central nervous system stimulant or sigma receptor agonist
JPH0135827B2 (de)
US4914092A (en) Benzothiazepin-4-one derivatives, their preparation and their application in therapy
US3798225A (en) 3(2h)-isoquinolones
AT383594B (de) Verfahren zum herstellen von neuen carbostyrilderivaten und ihren salzen
JPH05194405A (ja) カルボスチリル誘導体及び血小板凝集抑制剤
JP2010523498A (ja) セレクチンの阻害のための方法および組成物

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8102690-8

Effective date: 19940110

Format of ref document f/p: F